Last reviewed · How we verify

NCT06695975

Occupational Self Analysis in People with a Serious Mental Illness.

Completed NA Last updated 19 November 2024
What this trial tests

NA trial testing Occupational self-analysis in Intervention in 18 participants. Completed in 28 May 2022.

Timeline
8 November 2021
Primary endpoint
30 April 2022
28 May 2022

Quick facts

Lead sponsorUniversity of Malaga
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment18
Start date8 November 2021
Primary completion30 April 2022
Estimated completion28 May 2022
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Malaga

Who can join

18 and older, any sex, with Intervention or Control Condition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study we test the efectiveness of an intervention called 'Occupational sefl-analysys' where particiapants are taught to analyze what activities they do and why do they choose those activities. Also they are encouage to reflect about those occupations that don't do but will like to. In case they want to , they can make changes in their occupational routines. After he program we assessed the improvements in life satisfaction, participation in meaningful activities, perception of balance and occupational satisfaction,

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Intervention

Currently open trials in the same condition.

Other University of Malaga trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06695975.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing